ABMD Key Statistics, Chart & Performance
The current stock price of ABMD is 381.02 USD. In the past month the price increased by 0.8%. In the past year, price increased by 8.18%.
ABMD Latest News, Press Relases and Analysis
ABMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.66 | 222.87B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.23 | 207.51B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.36 | 150.19B | ||
| SYK | STRYKER CORP | 28.48 | 143.40B | ||
| IDXX | IDEXX LABORATORIES INC | 60.8 | 61.33B | ||
| BDX | BECTON DICKINSON AND CO | 13.56 | 56.03B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.78 | 50.38B | ||
| RMD | RESMED INC | 25.84 | 37.33B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.42 | 36.42B | ||
| DXCM | DEXCOM INC | 33.17 | 24.19B | ||
| PODD | INSULET CORP | 71.96 | 23.13B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 12 | 19.23B |
Related stock screener links
About ABMD
Company Profile
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company is headquartered in Danvers, Massachusetts and currently employs 2,003 full-time employees. The firm develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The firm's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.
Company Info
ABIOMED INC
22 Cherry Hill Dr
Danvers MASSACHUSETTS 01923 US
CEO: Michael R. Minogue
Employees: 2003
Phone: 19787775410.0
ABIOMED INC / ABMD FAQ
What does ABMD do?
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company is headquartered in Danvers, Massachusetts and currently employs 2,003 full-time employees. The firm develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The firm's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.
Can you provide the latest stock price for ABIOMED INC?
The current stock price of ABMD is 381.02 USD. The price increased by 0.06% in the last trading session.
What is the dividend status of ABIOMED INC?
ABMD does not pay a dividend.
How is the ChartMill rating for ABIOMED INC?
ABMD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the GICS sector and industry of ABMD stock?
ABIOMED INC (ABMD) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of ABMD stock?
ABIOMED INC (ABMD) has a market capitalization of 17.18B USD. This makes ABMD a Large Cap stock.
When does ABIOMED INC (ABMD) report earnings?
ABIOMED INC (ABMD) will report earnings on 2023-02-01.
ABMD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ABMD. When comparing the yearly performance of all stocks, ABMD is one of the better performing stocks in the market, outperforming 96.07% of all stocks.
ABMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ABMD. ABMD has an excellent financial health rating, but there are some minor concerns on its profitability.
ABMD Financial Highlights
Over the last trailing twelve months ABMD reported a non-GAAP Earnings per Share(EPS) of 4.84. The EPS decreased by -3.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.84% | ||
| ROA | 15.72% | ||
| ROE | 17.32% | ||
| Debt/Equity | 0 |
ABMD Forecast & Estimates
16 analysts have analysed ABMD and the average price target is 375.36 USD. This implies a price decrease of -1.49% is expected in the next year compared to the current price of 381.02.
For the next year, analysts expect an EPS growth of 3.83% and a revenue growth 10.29% for ABMD